Tissue distribution of 2-methoxyestradiol nanosuspension in rats and its antitumor activity in C57BL/6 mice bearing lewis lung carcinoma

Drug Delivery

Volumn 19, Issue 7, 2012, Pages 327-333

  Shen, G ^a   Wang, Q ^a   Zhang, Q ^a   Sun, H ^a   Zhao, Y ^a   Zhang, Z ^a   Du, B ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

2 methoxyestradiol; antitumor activity; cytotoxicity; lewis lung carcinoma; tissue distribution

Indexed keywords

2 METHOXYESTRADIOL; CYCLOPHOSPHAMIDE; LETROZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SUSPENSION; TISSUE DISTRIBUTION; TUMOR GROWTH; ZETA POTENTIAL;

ANIMALS; CARCINOMA, LEWIS LUNG; ESTRADIOL; FEMALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SUSPENSIONS; TISSUE DISTRIBUTION;

EID: 84867565969     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2012.721142     Document Type: Article

References (25)

1. Benttarari RR, Amit T, Youdim M. Binding of oestradiol, progesterone and prolactin in rat lung. J Endocrinol 1983;97:301-311.
2. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004;56:1649-1659. (Pubitemid 39177694)
3. Dobos J, Tímár J, Bocsi J, Burián Z, Nagy K, Barna G, Peták I, Ladányi A. In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. Int J Cancer 2004;112:771-776. (Pubitemid 39435261)
4. Du B, Li Y, Li XT, Youmei A, Zhang ZZ. LC with fluorescence detection for the tissue pharmacokinetics of 2-methoxyestradiol solution and liposome after intravenous administrations to rats. Chromatographia 2009;70:1287-1290.
5. Du B, Li XT, Zhao Y, A YM, Zhang ZZ. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders. Pharmazie 2010;65:471-476.
6. Garcia GE, Wisniewski HG, Lucia MS, Arevalo N, Slaga TJ, Kraft SL, Strange R, Kumar AP. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-α-stimulated gene 6. Clin Cancer Res 2006;12:980-988. (Pubitemid 43259881)
7. Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 2008;105:11613-11618.
8. Gui Y, Zheng XL. 2-methoxyestradiol induces cell cycle arrest and mitotic cell apoptosis in human vascular smooth muscle cells. Hypertension 2006;47:271-280. (Pubitemid 43189774)
9. Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N, Munshi N, Kharbanda S, Anderson KC. JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J Biol Chem 2003;278:17593-17596. (Pubitemid 36799359)
10. Hany SM, Peters Y, Nicholas B. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int J Pharm 2009;375:107-113.
11. Huang XH, Xiong PC, Xiong CM, Cai YL, Wei AH, Wang JP, Liang XF, Ruan JL. In vitro and in vivo antitumor activity of Macrothelypteris torresiana and its acute/subacute oral toxicity. Phytomedicine 2010;17:930-934.
12. Hughes RA, Harris T, Altmann E, McAllister D, Vlahos R, Robertson A, Cushman M, Wang Z, Stewart AG. 2-Methoxyestradiol and analogs as novel antiproliferative agents: analysis of three-dimensional quantitative structure-activity relationships for DNA synthesis inhibition and estrogen receptor binding. Mol Pharmacol 2002;61:1053-1069. (Pubitemid 34441770)
13. Huh JI, Calvo A, Charles R, Green JE. Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression. Cancer Res 2006;66:3495-3503.
14. Ireson CR, Chander SK, Purohit A, Perera S, Newman SP, Parish D, Leese MP, Smith AC, Potter BV, Reed MJ. Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br J Cancer 2004;90:932-937. (Pubitemid 38406609)
15. Lu B. New Techniques and New Dosage Forms of Drugs, 2nd ed. Bei Jing: People's Medical Publishing House, 2005:158-167.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. (Pubitemid 14203433)
17. Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: preparation by a size reduced technique. Int J Pharm 1998;160:229-237. (Pubitemid 28083096)
18. Peters K, Leitzke S, Diederichs JE, Borner K, Hahn H, Müller RH, Ehlers S. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J Antimicrob Chemother 2000;45:77-83. (Pubitemid 30060237)
19. Sève P, Reiman T, Dumontet C. The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer. Lung Cancer 2010;67:136-143.
20. Spivey KA, Banyard J, Solis LM, Wistuba II, Barletta JA, Gandhi L, Feldman HA, Rodig SJ, Chirieac LR, Zetter BR. Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev 2010;19:1362-1372.
21. Sweeney C, Liu G, Yiannoutsos C, Kolesar J, Horvath D, Staab MJ, Fife K, Armstrong V, Treston A, Sidor C, Wilding G. A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer. Clin Cancer Res 2005;11:6625-6633. (Pubitemid 41339003)
22. Wang Y, Zhang D, Liu Z, Liu G, Duan C, Jia L, Feng F, Zhang X, Shi Y, Zhang Q. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery. Nanotechnology 2010;21:155104-155110.
23. Zhang H, Hollis CP, Zhang Q, Li T. Preparation and antitumor study of camptothecin nanocrystals. Int J Pharm 2011;415:293-300.
24. Zheng D, Wang Y, Zhang D, Liu Z, Duan C, Jia L, Wang F, Liu Y, Liu G, Hao L, Zhang Q. In vitro antitumor activity of silybin nanosuspension in PC-3 cells. Cancer Lett 2011;307:158-164.
25. Zhu WJ, Han B, Sun Y, Wang ZY, Yang XH. Immunoregulatory effects of a glucogalactan from the root of Panax quinquefolium L. Carbohyd Polym 2011;87:2725-2729.